DR. CAROLIN BARTH JOINS MIROBIO AS CEO TO LEAD PRECISION IMMUNOLOGY COMPANY FOCUSED ON CHECKPOINT AGONIST ANTIBODIES Former Novartis executive to lead emerging biotech with a novel precision approach to…
Read More
Exscientia enters $70M collaboration to develop anti-viral therapeutics against Coronavirus and other viruses with pandemic potential Four-year agreement with Bill & Melinda Gates Foundation to discover and develop small molecule…
Regulatory approval of OVM-200 for Phase 1 signals a significant step for Oxford Vacmedix with the first clinical trial of a cancer vaccine based on the recombinant overlapping peptide platform…
Significant expansion of AI firm Exscientia’s headquarters at TOSP Job creation to continue beyond 100 roles added already this year Oxford, UK, August 4 2021 – Exscientia, the clinical stage,…
Dr. David Ruau joins Sensyne Health from Bayer Pharmaceuticals Oxford, U.K. 22 July 2021: Sensyne Health plc (LSE: SENS) (“Sensyne” or the “Company”), the ethical AI company, today announces the appointment…
Oxford, UK – July 20, 2021 – Orbit Discovery Ltd., (“Orbit”), a privately held biopharmaceutical company focused on discovering candidate peptide therapeutics harnessing proprietary affinity and cell-based functional screening platforms, today…
T-Cypher Bio announces the appointment of Thomas Lars Andresen as Chief Executive Officer Company to be led by award winning, cell therapy expert as it aims to unlock an expansive…
Etcembly establishes new lab & office space at TOSP Immune-focused machine learning firm joins leading AI cohort on Park Oxford, UK, July 8 2021 – Etcembly Ltd, a machine learning…
Nature Biotechnology publishes ATDBio & University of Oxford single-cell sequencing research Better understanding of disease possible with accurate full length identification of all messenger RNA in a cell Oxford, UK,…
Oxford, United Kingdom, June 29, 2021: Orbit Discovery Ltd (“Orbit”), a biopharmaceutical company focused on discovering candidate peptide therapeutics using high throughput microfluidic platforms, has announced the appointment of Dr Neil…
Innovative herbicide discovery firm MoA Technology moves to TOSP Third occupier for Bellhouse Building at The Oxford Science Park Oxford, UK, June 28 2021 – MoA Technology, which is focused…
ATDBio establishes molecular diagnostics lab to support customer research Leading nucleic acid maker evolves activity & builds on pandemic experience Oxford, UK, June 21 2021 – ATDBio, a leading…
Deep learning platform evaluates drug activity in patient tumour microenvironments with single cell resolution First AI platform clinically validated to improve treatment outcomes in prospective study Exscientia, a clinical stage…
We are delighted to announce the winners of the prestigious 2020 OBN Awards, presented on Friday 11 June at the Royal Lancaster in London. The Awards, which are in their 12th year, shine…
Cytox welcomes FDA’s approval of Biogen’s Aduhelm (aducanumab) to treat Alzheimer’s disease Cytox genoSCORE-LAB test can identify patients most at risk of cognitive decline, and potentially most likely to benefit…